Search for: "Allergan, Inc."
Results 301 - 320
of 388
Sort by Relevance
|
Sort by Date
16 Mar 2011, 12:26 pm
Allergan USA, Inc., 2009 WL 3294873, at *2-5 (D. [read post]
10 Mar 2011, 8:06 am
” The very next day, Ball is set to become the new CEO and a director at Hospira, Inc. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
4 Mar 2011, 2:48 am
Allergan, Inc., No. 10 C 2414, Slip Op. [read post]
28 Jan 2011, 3:31 am
" Bloomberg News says, "Allergan Inc. and Johnson & Johnson" breast implants were linked to ALCL by US investigators. [read post]
28 Jan 2011, 2:27 am
” Bloomberg News says, “Allergan Inc. and Johnson & Johnson” breast implants were linked to ALCL by US investigators. [read post]
27 Jan 2011, 8:15 am
., implants are sold by Allergan Inc. and Johnson & Johnson unit Mentor. [read post]
27 Jan 2011, 5:00 am
Allergan, Inc., 2011 WL 147714 (C.D. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
10 Dec 2010, 2:31 pm
" "Release controlling polymer" Allergan, Inc. v. [read post]
9 Dec 2010, 12:50 pm
Cyberonics, Inc., 654 F. [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and… [read post]
3 Dec 2010, 5:53 am
Allergan, Inc., 1-10-cv-02414 (ILND November 30, 2010, Order) (St. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
29 Oct 2010, 10:52 am
Allergan, Inc., the maker of wrinkle-smooting Botox, has agreed to pay $600 million to settle a year-long federal investigation into its marketing of the top-selling, botulin-based drug. [read post]
27 Oct 2010, 8:57 am
" AP reports, Topping the list was specialty drugmaker Allergan Inc. which paid out $600 million to settle allegations that it marketed the anti-wrinkle injection Botox for unapproved uses. [read post]
27 Oct 2010, 8:57 am
" AP reports, Topping the list was specialty drugmaker Allergan Inc. which paid out $600 million to settle allegations that it marketed the anti-wrinkle injection Botox for unapproved uses. [read post]
25 Oct 2010, 9:55 pm
Sandoz Inc. v. [read post]
25 Oct 2010, 10:22 am
Patent No. 7,405,203 owned by Allergan, Inc. and entitled PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN. [read post]
19 Oct 2010, 9:00 am
Botox is manufactured by Allergan Inc. of Irvine, Calif. [read post]
